National institute of neurological disorders and stroke-canadian stroke network vascular cognitive impairment harmonization standards

One in 3 individuals will experience a stroke, dementia or both. Moreover, twice as many individuals will have cognitive impairment short of dementia as either stroke or dementia. The commonly used stroke scales do not measure cognition, while dementia criteria focus on the late stages of cognitive...

Full description

Saved in:
Bibliographic Details
Published in:Stroke (1970) 2006-09, Vol.37 (9), p.2220-2241
Main Authors: HACHINSKI, Vladimir, IADECOLA, Costantino, VINTERS, Harry V, HOLTZMAN, David M, ROSENBERG, Gary A, DICHGANS, Martin, MARLER, John R, LEBLANC, Gabrielle G, PETERSEN, Ron C, BRETELER, Monique M, NYENHUIS, David L, BLACK, Sandra E, POWERS, William J, DECARLI, Charles, MERINO, Jose G, KALARIA, Raj N
Format: Article
Language:English
Subjects:
Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
Brain - pathology
Cerebrovascular Disorders - complications
Cognition Disorders - diagnosis
Cognition Disorders - epidemiology
Cognition Disorders - etiology
Cognition Disorders - psychology
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Magnetic Resonance Imaging
Medical sciences
Nervous system (semeiology, syndromes)
Neurology
Neuropsychological Tests
Pharmacology. Drug treatments
Vascular diseases and vascular malformations of the nervous system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:One in 3 individuals will experience a stroke, dementia or both. Moreover, twice as many individuals will have cognitive impairment short of dementia as either stroke or dementia. The commonly used stroke scales do not measure cognition, while dementia criteria focus on the late stages of cognitive impairment, and are heavily biased toward the diagnosis of Alzheimer disease. No commonly agreed standards exist for identifying and describing individuals with cognitive impairment, particularly in the early stages, and especially with cognitive impairment related to vascular factors, or vascular cognitive impairment. The National Institute for Neurological Disorders and Stroke (NINDS) and the Canadian Stroke Network (CSN) convened researchers in clinical diagnosis, epidemiology, neuropsychology, brain imaging, neuropathology, experimental models, biomarkers, genetics, and clinical trials to recommend minimum, common, clinical and research standards for the description and study of vascular cognitive impairment. The results of these discussions are reported herein. The development of common standards represents a first step in a process of use, validation and refinement. Using the same standards will help identify individuals in the early stages of cognitive impairment, will make studies comparable, and by integrating knowledge, will accelerate the pace of progress.
ISSN:0039-2499
1524-4628
DOI:10.1161/01.STR.0000237236.88823.47